Indefinite Delivery Contract SPE2DX16D3924

The Indefinite Delivery Contract (IDC) SPE2DX16D3924 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The single-award contract, valued at up to $4,999,999.00, runs through November 2023 and covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical medical commodities across various therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, and infectious disease prevention. As the prime contractor, Amerisourcebergen Drug Corp leverages its extensive pharmaceutical distribution capabilities and supply chain network to efficiently fulfill the government's requirements for essential medical products. This IDC serves as a primary vehicle for the DLA to procure necessary pharmaceuticals and medical supplies to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism.

Additionally, Cencora, Inc., the parent company of Amerisourcebergen Drug Corp, holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs demonstrate Cencora, Inc.'s capacity to support the diverse pharmaceutical and medical supply requirements of multiple government agencies, contributing to the overall healthcare readiness and delivery for federal healthcare programs.